To illustrate the potential utility of restricted biomarkers, we compared the performance of CD27+ CD28+ CD4+ TEM frequency as a biomarker of hepatitis risk in our unrestricted and restricted datasets (Fig. 7). This evidence concerns the gene CD27 and Hepatitis.